INV-144

· InVasc Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for INV-144, covering 2012-08-07 to 2012-08-07. Get the full timeline:

Most recent: Clinical Trial Update: INV-144 Versus Losartan in Hypertension and Type 2 Diabetes Mellitus Patients With Macroalbuminuria [Phase 2]